Baylor Scott & White Institute for Rehabilitation - Dallas
Dallas, Texas, 75246, United States
NCT Number: NCT03874988
This study's overarching aim is to follow a systematic approach that incorporates community-based participatory research (CBPR) to develop a multi-component weight loss intervention that may yield significant effects for a chronic SCI sample. The approach is to obtain data on the 3 unique strategies (prepackaged/portion-controlled meals; enhanced self-monitoring; the GLB-SCI) to inform design of an empirically supported and consumer-validated multicomponent intervention program, that combines the best of the 3 approaches into one unique intervention, the GLB SCI+. Based on the investigators' prior experience with adapting and delivering the GLB AIM (a lifestyle intervention previously adapted for those with impaired mobility), interim findings, existing literature, and consumer feedback, they hypothesize that these 3 unique strategies may confer individualized benefits to people with SCI given their complex disability-related barriers to weight loss.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Dallas, Texas, 75246, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive portion-controlled meals with the aim of encouraging weight loss and healthier eating.
Participants will be encouraged to track their physical activity, food intake, and weight using technology that will be provided as part of the study.
Participants will take part in a lifestyle intervention program (tailored for spinal cord injury needs) that encourages steady weight loss through increased physical activity and healthier diet patterns.
Participants will receive a combination of the prior interventions studied, with the goal of showing that a multi-component intervention will be the most effective in encouraging weight loss among participants with a spinal cord injury.
Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.
Change in weight (pounds) will be measured after each 13-week intervention.
Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.
Change in self-reported physical activity (minutes per week) will be measured after each 13-week intervention to assess whether the intervention effectively encouraged greater levels of physical activity.
Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.
Self-efficacy will be measured through changes in the Self-Rated Abilities for Health Practices Scale from baseline to post-intervention. The questionnaire contains 28 items that are on a 5-point scale. It was designed to measure a person's perception of his/her own ability to practice "healthy" behaviors and has 4 sub-scales with 7 items each: Exercise, Nutrition, Responsible Health Practice, and Psychological Well Being. Ratings for each subscale are summed to yield subscale scores and subscale scores are summed to obtain a total score. Higher scores indicate greater confidence in one's ability to perform health practices and total scores range from 0-112.
Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.
Changes in self-reported levels of function and quality of life will be assessed through the LIFE-H survey, given before and after each intervention. The Assessment of Life Habits (LIFE-H) assesses a person's self-reported difficulty with and need for assistance performing tasks associated with activities of daily living (ADL) and social roles. The version used for this study covers 6 ADL categories: nutrition, fitness, personal care, communication, residence, mobility and 6 social role categories: responsibility, interpersonal relations, community, education, employment, recreation. Scoring is based on respondent rating of level of accomplishment (No difficulty to Not accomplished) combined with the type of assistance (if any) used to perform these tasks. Scores range from 9 to 0, with higher scores indicating less difficulty.
Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.
Participants will have their waist circumference measured before and after each intervention to assess the level of change, if any.
Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.
Participants will have their blood pressure measured before and after each intervention to assess the level of change, if any.
Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.
Participants will have their hemoglobin A1c measured before and after each intervention assess the level of change, if any.
Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.
Participants will have their levels of motivation assessed before and after each intervention with the Treatment Self-Regulation Questionnaire. The 18-item Treatment Self-Regulation Questionnaire is derived from self-determination theory and yields 2 subscales: autonomous regulation (or intrinsic motivation) and controlled regulation (or extrinsic motivation). Responses are provided on a 7-point Likert type scale ranging from 1 'not at all true' to 7 'very true,' and includes the option of "not applicable." Autonomous Regulation scores are obtained by averaging questions 3, 4, 9, 13, 17, 18 and Controlled Regulation scores are obtained by averaging questions 1, 2, 5, 6, 7, 8, 10, 11, 12, 14, 15, 16. Higher scores indicate higher levels of motivation. Higher scores indicate higher levels of each type of regulation.
Time frame: Attendance will be tracked over the entire 13-week intervention.
Intervention arms involving meeting on a regular basis will have attendance tracked to assess the overall feasibility of the intervention and to examine correlations between self-monitoring and weight-loss.
Time frame: Adherence will be tracked over the entire 13-week intervention.
Intervention arms involving self-monitoring food intake and physical activity will have levels of adherence tracked to assess the overall feasibility of the intervention and to examine correlations between self-monitoring and weight-loss.
Time frame: Attendance will be tracked over the entire 13-week intervention.
Intervention arms involving teleconference meeting attendance will have levels of adherence tracked to examine correlations between attendance and weight-loss.
Time frame: Perception will be assessed at the end of the 13-week intervention.
Participant perceptions will be assessed using a survey that asks participants to rate on a scale of 1 - 5 each active component used in each study
Baylor Research Institute
Other
Acronym: GLB-SCI+
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04109586
Body Weight, Central Nervous System Diseases
Nesoddtangen, Bjørnemyr, Norway
View Trial DetailsNCT04748835
Behavior, Behavior, Animal
Dallas, Texas, United States
View Trial DetailsNCT03292315
Body Weight, Central Nervous System Diseases
West Orange, New Jersey, United States
View Trial DetailsNCT02630524
Body Weight, Central Nervous System Diseases
Birmingham, Alabama, United States
View Trial Details